Virginia Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a contractual agreement outlining the terms and conditions of the collaboration. The purpose of this agreement is to establish a framework for the commercialization of intellectual property developed through joint research endeavors and to protect the rights of both parties involved. By entering into this agreement, both Gentling, Inc. and The University of North Texas Health Science Center aim to foster innovation and maximize the potential value of their respective technologies. The Virginia Collateral License Agreement encompasses various aspects and provisions that are essential for a successful partnership. One of the key components is the granting of a license by the University to Gentling, Inc. for the use of specific intellectual property owned by the University. This license enables Gentling, Inc. to exploit, develop, and commercialize the licensed technology. Additionally, the agreement establishes guidelines for revenue sharing and royalties generated from the licensed technology. This ensures that both parties benefit from any potential financial upside resulting from the commercialization efforts. The specifics of the revenue sharing and royalty structure are typically outlined in detail within the agreement, taking into consideration factors such as development costs, marketing efforts, and future sales projections. Furthermore, the Virginia Collateral License Agreement may also include provisions related to confidentiality and non-disclosure, ensuring that proprietary information shared during the collaboration is safeguarded and used solely for the intended purposes. This protects the intellectual property rights of both Gentling, Inc. and The University of North Texas Health Science Center. Depending on the nature of their collaboration, Gentling, Inc. and The University of North Texas Health Science Center may have multiple types of Virginia Collateral License Agreements. These may include agreements specific to different technologies, projects, or fields of research that they are jointly involved in. Each agreement would be tailored to address the unique circumstances and requirements of the respective collaboration. In conclusion, the Virginia Collateral License Agreement serves as a crucial document in establishing a successful partnership between Gentling, Inc. and The University of North Texas Health Science Center. It outlines the terms, rights, and obligations of both parties in relation to the commercialization of intellectual property developed through joint research efforts. By forging this agreement, both organizations aim to maximize the potential value of their technologies and promote innovation in their respective fields.

The Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a contractual agreement outlining the terms and conditions of the collaboration. The purpose of this agreement is to establish a framework for the commercialization of intellectual property developed through joint research endeavors and to protect the rights of both parties involved. By entering into this agreement, both Gentling, Inc. and The University of North Texas Health Science Center aim to foster innovation and maximize the potential value of their respective technologies. The Virginia Collateral License Agreement encompasses various aspects and provisions that are essential for a successful partnership. One of the key components is the granting of a license by the University to Gentling, Inc. for the use of specific intellectual property owned by the University. This license enables Gentling, Inc. to exploit, develop, and commercialize the licensed technology. Additionally, the agreement establishes guidelines for revenue sharing and royalties generated from the licensed technology. This ensures that both parties benefit from any potential financial upside resulting from the commercialization efforts. The specifics of the revenue sharing and royalty structure are typically outlined in detail within the agreement, taking into consideration factors such as development costs, marketing efforts, and future sales projections. Furthermore, the Virginia Collateral License Agreement may also include provisions related to confidentiality and non-disclosure, ensuring that proprietary information shared during the collaboration is safeguarded and used solely for the intended purposes. This protects the intellectual property rights of both Gentling, Inc. and The University of North Texas Health Science Center. Depending on the nature of their collaboration, Gentling, Inc. and The University of North Texas Health Science Center may have multiple types of Virginia Collateral License Agreements. These may include agreements specific to different technologies, projects, or fields of research that they are jointly involved in. Each agreement would be tailored to address the unique circumstances and requirements of the respective collaboration. In conclusion, the Virginia Collateral License Agreement serves as a crucial document in establishing a successful partnership between Gentling, Inc. and The University of North Texas Health Science Center. It outlines the terms, rights, and obligations of both parties in relation to the commercialization of intellectual property developed through joint research efforts. By forging this agreement, both organizations aim to maximize the potential value of their technologies and promote innovation in their respective fields.